Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 Gene

• Published in: Neoplasia (New York, N.Y.) Vol. 5; no. 6; pp. 481 - 488
• Main Authors: Raaphorst, Frank M., Meijer, Chris J.L.M., Fieret, Elly, Blokzijl, Tjasso, Mommers, Ellen, Buerger, Horst, Packeisen, Jens, Sewalt, Richard A.B., Ottet, Arie P., van Diest, Paul J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2003; Neoplasia Press Inc; Elsevier
• Subjects: BMI-1; Breast - metabolism; breast cancer; Breast Neoplasms - metabolism; Carcinoma, Intraductal, Noninfiltrating - metabolism; DNA-Binding Proteins - biosynthesis; Enhancer of Zeste Homolog 2 Protein; EZH2; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Neoplasm Invasiveness; Nuclear Proteins - biosynthesis; Polycomb; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Precancerous Conditions - metabolism; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins - biosynthesis; Repressor Proteins; tissue array; Transcription Factors; tissue array; PRC; BMI-1; DH; PcG; DCIS; Polycomb; breast cancer; EZH2
• ISSN: 1476-5586; 1522-8002; 1476-5586; 1522-8002
• DOI: 10.1016/S1476-5586(03)80032-5

Polycomb group (PcG) genes contribute to the maintenance of cell identity, cell cycle regulation, and oncogenesis. We describe the expression of five PcG genes (BMI-1, RING1, HPC1, HPC2, and EZH2) in normal breast tissues, invasive breast carcinomas, and their precursors. Members of the HPC-HPH/PRCi PcG complex, including BMI-1, RING1, HPCi, and HPC2, were detected in normal resting and cycling breast cells. The EED-EZH/PRC2 PcG complex protein EZH2 was only found in rare cycling cells, whereas normal resting breast cells were negative for EZH2. PcG gene expression patterns in ductal hyperplasia (DH), welldifferentiated ductal carcinoma in situ (DCIS), and welldifferentiated invasive carcinomas closely resembled the pattern in healthy cells. However, poorly differentiated DCIS and invasive carcinomas frequently expressed EZH2 in combination with HPC-HPH/PRCi proteins. Most BMI-1/EZH2 double-positive cells in poorly differentiated DCIS were resting. Poorly differentiated invasive carcinoma displayed an enhanced rate of cell division within BMI-1/EZH2 double-positive cells. We propose that the enhanced expression of EZH2 in BMI-1+ cells contributes to the loss of cell identity in poorly differentiated breast carcinomas, and that increased EZH2 expression precedes high frequencies of proliferation. These observations suggest that deregulated expression of EZH2 is associated with loss of differentiation and development of poorly differentiated breast cancer in humans.